Urethritis secondary prevention
Urethritis Microchapters | |
Diagnosis | |
Treatment | |
Case Studies | |
Urethritis secondary prevention On the Web | |
American Roentgen Ray Society Images of Urethritis secondary prevention | |
Risk calculators and risk factors for Urethritis secondary prevention | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]
Overview
In order to prevent transmission to partner and decrease the risk of antibiotic resistance all patients must be instructed for safe sex practicing and screening after treatment.
Secondary Prevention
- Patients should be instructed in safe sex practice.
- All sex partners within the last 60 days must be evaluated for possible urethritis.
- Patients should be screened for other sexually transmitted diseases e.g. HIV and syphilis.
- All patients must be retested 3 months after treatment to evaluate the risk of resistance
- Prophylactic ocular antimicrobial medication is strongly recommended for all newborns exposed to Neisseria gonorrhoeae during birth
- Gonorrhea and chlamydia are reportable diseases per the CDC, and practitioners should contact their local state health department[1][2][3]
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 9781455748013.
- ↑ Workowski KA, Bolan GA (2015). "Sexually transmitted diseases treatment guidelines, 2015". MMWR Recomm Rep. 64 (RR-03): 1–137. PMID 26042815.
- ↑ Brill JR (2010). "Diagnosis and treatment of urethritis in men". Am Fam Physician. 81 (7): 873–8. PMID 20353145.